Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Advisory committee recommends approval of non-nicotine smoking cessation product

Dec. 13, 1996

NDA filed for Antizol

Dec. 13, 1996

New use claimed for olanzapine

Nov. 26, 1996

LecTec cleared to proceed with clinical testing of smoking cessation product

Nov. 22, 1996

Cocaine vaccine nearing clinic

Nov. 8, 1996

New therapeutic for smoking cessation to enter pivotal trials

Oct. 25, 1996

Nicotine inhaler for smoking cessation: Clinical trial results

Oct. 25, 1996

Cangene acquires iron chelator from Apotex

Oct. 18, 1996

Japanese scientists discover potential agent for siderosis

Oct. 11, 1996

Cocaine vaccine proven effective in animal model

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...